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Identity 
Alias: Poikiloderma atrophicans and cataract 
Note 
RTS is a chromosomal instability syndrome with an 
increased risk of cancers. 
Inheritance 
Autosomal recessive; rare geno-dermatosis with 
increased frequency in females; more than 200 
cases reviewed in the medical literature. 
Clinics 
Phenotype and clinics 
Clinical expression highly variable.  
Main features include:  
- growth retardation,  
- skin defects appearing within the first year of life 
(90%): atrophic dermatosis, poikiloderma, 
hyperpigmentation, teleangiectasia,  
- sparse hair which may progress to partial or total 
alopecia; dystrophic nails,  
- photosensitivity,  
- congenital skeletal defects: hypoplasia or absence 
of the radii and thumbs, osteopenia, cystic or 
sclerotic changes of the long bones (in more than 
50%); bone age lower than chronological age,  
- juvenile cataract, corneal dystrophy (50%),  
- hypodontia,  
- hypogonadism (25%),  




- premature aging.  
Diagnosis: the diagnosis is difficult before the 
development of the erythema. 
Differential Diagnosis 
Differential diagnosis with: Werner syndrome, 
dyskeratosis congenita, Cockayne syndrome, 
Anhidrotic ectodermal dysplasia, Bloom syndrome, 
Fanconi anaemia. 
Neoplastic risk 
There are more than 30 documented cases of 
malignancies in RTS patients, predominantly 
affecting skin (squamous cell carcinoma, basal cell 
carcinoma) and bone (osteosarcoma).  
Etiology is unknown; a DNA repair deficiency has 
been postulated to account for cancer proneness, 
but no conclusive results have so far been achieved. 
Treatment 
Only protection against sunlight is possible; 
dermatologic therapies; surgical correction of 
skeletal malformations and cataracts; regular and 
careful work-up of signs and symptoms of both 
cutaneous and internal malignancy; caution is 
warranted in administering chemotherapy to 
affected individuals due to their sensitivity to 
chemotherapeutic agents. 
Evolution 
The disease tends to progress during the first years 
of life, but becomes static so that patients may have 
a normal lifespan; the mortality from neoplastic 
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Spontaneous/induced chromatid breaks were found 
increased in only a very few studies; In contrast 
with (mainly negative) chromatid results, consistent 
clonal/non clonal structural chromosomal 
abnormalities were evidenced in most studies, often 
involving chromosome 8, in cultured lymphocytes 
and in fibroblasts; low frequency trisomy 8 
mosaicism has been reported in both lymphocyte 
and primary fibroblast cultures as well as in 
uncultured blood and buccal smears, indicating this 
characteristic chromosomal abnormality is present 
in vivo; a propensity to centromere misdivision 
with development of clones carrying 
isochromosomes, such as i(8q), is peculiar of RTS. 
Cytogenetics of cancer 
Marked chromosomal instability has been detected 
in mesenchymal tumours developed by RTS sibs. 
Other findings 
Note 
Reduced unscheduled DNA synthesis, 37% of 
normal after exposure to ultraviolet C or gamma 
irradiation. 
Genes involved and 
proteins 
Note 
The gene has not been mapped; it has been 
provisionally assigned to chromosome 8 on the 
basis of trisomy 8 mosaicism in affected 
individuals; no linkage studies exploiting 
homozygosity mapping have been performed due to 
the few reported families. 
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